Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Efesovir (1 trial)
Tuberculosis (Phase 3)
Tuberculosis, Multidrug-Resistant (Phase 3)
Trials (1 total)
Trial APIs (1 total)